-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Downgrades Medpace Holdings to Neutral, Raises Price Target to $547

Benzinga·07/08/2026 09:36:15
Listen to the news
Baird analyst Eric Coldwell downgrades Medpace Holdings (NASDAQ:MEDP) from Outperform to Neutral and raises the price target from $477 to $547.